Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014

Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results
                         on Thursday, August 7, 2014

PR Newswire

REDWOOD CITY, Calif., July 23, 2014

REDWOOD CITY, Calif., July 23, 2014 /PRNewswire/ --Cardica, Inc. (Nasdaq:
CRDC) today announced that it will release financial results for its fiscal
fourth quarter and year ended June 30, 2014, on Thursday, August 7, 2014,
after the markets close. Cardica's management will host a conference call at
4:30 p.m. Eastern Time to discuss the financial results and provide an update
on the company's business.

Conference Call Details
To access the live conference call on August 7, 2014, at 4:30 p.m. Eastern
Time via phone, please dial 866-953-6859 from the United States and Canada or
617-399-3483 internationally. The conference ID is 25697752. Please dial in
approximately 10 minutes prior to the start of the call. A telephone replay
will be available beginning approximately four hours after the call through
August 14, 2014, and may be accessed by dialing 888-286-8010 from the United
States and Canada or 617-801-6888 internationally. The replay passcode is

To access the live and subsequently archived webcast of the conference call,
go to the Investor Relations section of the company's website at Please connect to the website at least 15 minutes prior to
the presentation to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents
Network. Individual investors can listen to the call at,
Thomson's individual investor portal, powered by StreetEvents. Institutional
investors can access the call via Thomson StreetEvents at, a password-protected event management site.

About Cardica
Cardicadesigns and manufactures proprietary stapling and anastomotic devices
for laparoscopic and cardiac surgical procedures.Cardica's technology
portfolio is intended to reduce operating time and facilitate
minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter
XCHANGE^® 30, a cartridge-based articulating surgical stapling device with a
five-millimeter shaft diameter, is manufactured and cleared for use in a
variety of gastrointestinal procedures and appendectomies in the United
States, and is marketed for a wide range of surgical procedures in Europe.
Cardicais developing the Cardica^® MicroCutter XCHANGE^® 45, a
cartridge-based microcutter device that is being designed with an
eight-millimeter shaft to be used in a variety of procedures, including
bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter
XCHANGE 45 product requires 510(k) clearance and CE Mark before it may be sold
in the United States and Europe, respectively, and is not yet commercially
available in the U.S. or internationally. In addition, Cardica manufactures
and markets its automated anastomosis systems, the C-Port^® Distal Anastomosis
Systems and PAS-Port^® Proximal Anastomosis System for coronary artery bypass
graft (CABG) surgery, and has shipped over 50,000 units throughout the world.

SOURCE Cardica, Inc.

Contact: Bob Newell, Vice President, Finance and Chief Financial Officer,
(650) 331-7133,
Press spacebar to pause and continue. Press esc to stop.